Celldex Therapeutics Inc. (CLDX) Slipped -11.4% or -0.58 To Price $4.51 On Tuesday


Celldex Therapeutics Inc. (CLDX) slipped -11.4% or -0.58 to $4.51. It is nearly 1.26 million shares traded, which is 371.27% compare to the average total volume 340479. The market cap of CLDX is $56.10 million. The year to date change is 24.01%. The 52 week price range is from $2.75 to $34.95. Price of CLDX have changed -3.78% during last week. It have changed -4.68% over last month, 35.41% over last 3 months, -22.88% over last 6 months and -84.14% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLDX is 5.59. It is 23.95% above current price. The 200-day Moving Averages for CLDX is 5.94. It is 31.71% above current price. The 52-week High is 34.95. It is 674.94% from the current price. The 52-week Low is 2.75. It is -39.02% from current price.

There are some statistics of CLDX. It is has market cap $56.10 million. The share outstanding is 12.44 million. The average volume is 340479. The percent of top 15 Institution holding is 36.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLDX is -86.31%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLDX is -66.03%.


Tags:

Share this post